Fingerprint
Dive into the research topics of 'A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis
Donald E. Goodkin, M. Shulman, J. Winkelhake, E. Waubant, P. B. Andersson, T. Stewart, S. Nelson, N. Fischbein, P. K. Coyle, Elliot Frohman, L. Jacobs, J. Holcenberg, M. Lee, S. Mocci
Research output: Contribution to journal › Article › peer-review
44
Scopus
citations